In a scenario that could have been swiped from a spy series like “Homeland,” the U.S. Food and Drug Administration issued a safety alert last week about the vulnerability to hacking of up to 750,000 implantable heart defibrillators used to correct life-threatening arrhythmias, raising novel considerations for in-house and outside counsel.
The March 21 alert warned health care providers and individuals using certain Medtronic implantable cardiac defibrillators of cybersecurity weaknesses in their wireless technology that could leave the devices exposed to hacking. The FDA said it had received no reports of patient harm related to the vulnerability.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]